Search results
Results from the WOW.Com Content Network
As many as 39% of the children had resolution of symptoms immediately or within weeks of the diagnosis. Vomiting had resolved at the time of follow-up in 61% of the sample. Many children, including those in the remitted group, continued to have somatic symptoms such as headaches (in 42%) and abdominal pain (in 37%). [18]
Trials in emergency department settings support the use of ondansetron to abort vomiting episodes associated with gastroenteritis and dehydration. [20] A randomized controlled trial using a single dose of oral ondansetron in children with presumably viral gastroenteritis found it to be highly effective in stopping vomiting and increasing the effectiveness of oral rehydration therapy, thereby ...
In 1980, gastroenteritis from all causes caused 4.6 million deaths in children, with the majority occurring in the developing world. [73] Death rates were reduced significantly (to approximately 1.5 million deaths annually) by 2000, largely due to the introduction and widespread use of oral rehydration therapy . [ 80 ]
SUDC is rare, with a reported incidence in the United States of 1.2 deaths per 100,000 children, compared to 54 deaths per 100,000 live births for SIDs. There are approximately 400 deaths per year of SUDC in the U.S, with over 200 of these cases being the children aged 1–4 years. [3] SUDC deaths have occurred at the following sites: [4]
The use of intravenous lipid emulsion may also be tried. [3] In the early 2000s, TCAs were one of the most common causes of poisoning. [1] In the United States in 2004 there were more than 12,000 cases. [2] In the United Kingdom they resulted in about 270 deaths a year. [1] An overdose from TCAs was first reported in 1959. [1]
Symptoms like insomnia can be mediated by making a few smart adjustments to your routine. ... with an increased risk for thoughts of death and/or behavior in children and/or young adults ...
Medications include ondansetron, granisetron, and dolasetron. Anticholinergics can be used as a long-acting patch placed behind the patient's ear. Adverse effects include dry mouth and blurry vision. Care must be taken when handling the patch, as transfer of medication to the eye can induce pupillary dilation. Avoid use in elderly patients.
Prochlorperazine, dimenhydrinate, ondansetron (sold under the brand-name Zofran) or corticosteroids may be used if these are not effective. [3] [4] Hospitalization may be required due to the severe symptoms associated. [9] [3] Psychotherapy may improve outcomes. [3] Evidence for acupressure is poor. [3]